Categories Technology, U.S. Markets News

Apple rout deepens after Qualcomm wins partial ban on iPhone sales in Germany

The ongoing patent infringement litigation between Apple (AAPL) and Qualcomm (QCOM) took a new turn this week after the latter won another case, securing a ban on the sale of some older versions of iPhone in the German market. The feud, which started after Apple shunned Qualcomm and diverted its microprocessor orders to Intel (INTC), seems to be taking a toll on the fortunes of both the companies.

After the German court issued an injunction order in favor of Qualcomm, in one of the many lawsuits filed by the companies against each other, Apple confirmed it will withdraw some of the iPhone models from its stores in Germany.

The setback comes on the heels of Apple losing a case in China for allegedly using a combination of third-party chips and parts in iPhone, in violation of Qualcomm’s patents called ‘envelope tracking.’ Currently, the tech giant is facing a partial ban on the sale of iPhone in the Chinese market.

After a German court issued the injunction order, Apple confirmed it will withdraw some of the iPhone models from its stores in Germany

Dismissing the case as Qualcomm’s “tactics to disrupt innovation,” Apple’s management said it will appeal the ruling by the German court. The observation was backed by Intel, which supplies advanced chips for certain iPhone models.

Pursuant to the ban, which is limited to the outlets owned by Apple, iPhone 7 and iPhone 8 will soon disappear from the stores operating in Germany. While the other variants of the smartphone will be sold in the Apple stores, third-party stores will continue to sell all the models.

Apple has grand expansion plans for the US

While issuing the order, the Munich court said, “The ruling effectively outlaws the offering and placing on the market of the finished product in Germany, including the sale. The iPhones 7plus, 7, 8, 8plus and X are affected.”

Apple’s stock dropped sharply Thursday afternoon and closed the session down 3%, extending the downfall that started last month amid concerns of the faltering iPhone sales.

Having secured favorable rulings from two important courts in separate regions, Qualcomm’s efforts to safeguard its patented technologies got a major boost. The cases are linked to a lawsuit filed by Apple several months ago claiming that Qualcomm tried to monopolize its modem processors through anti-competitive practices.


Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips

Most Popular

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated

Add Comment
Viewing Highlight